Oncternal TherapeuticsONCT
13F holders, Q1 2024 (March 31)24holders
2famous investors
$9.00avg. 13F price*
At the end of Q1 2024, 24 institutions reported holding Oncternal Therapeutics Inc. (ONCT) in their 13F filings. The largest holders were Vanguard Group Inc. ($1.3M), Millennium Management ($928K) and BlackRock Inc. ($354K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Oncternal Therapeutics Inc.
- CUSIP
- 68236P206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $966K |
| Exits | 2 | $29K |
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | No change | 143,043 | $1.3M |
| Millennium Management | 0.00% | Add +0.3% | 103,095 | $928K |
| BlackRock Inc. | 0.00% | No change | 39,278 | $354K |
| Quantum Private Wealth, LLC | 0.09% | New | 27,806 | $250K |
| Dimensional Fund Advisors LP | 0.00% | New | 25,892 | $233K |
| Richmond Brothers, Inc. | 0.41% | No change | 24,696 | $222K |
| Geode Capital Management, LLC | 0.00% | New | 24,079 | $217K |
| Brighton Jones LLC | 0.01% | New | 16,923 | $152K |
| Renaissance Technologies | 0.00% | Add +3.3% | 16,905 | $152K |
| Morgan Stanley | 0.00% | Add +132.3% | 10,800 | $97K |
| Susquehanna International Group, LLP | 0.00% | New | 10,194 | $92K |
| ADAR1 Capital Management, LLC | 0.01% | New | 2,472 | $22K |
| Acadian Asset Management LLC | 0.00% | Reduce -46.4% | 1,949 | $17K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,004 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +167.6% | 664 | $6K |
| Wells Fargo & Company | 0.00% | Add +0.4% | 322 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -35.1% | 287 | $3K |
| North Star Investment Management Corp. | 0.00% | Reduce -95.0% | 250 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -0.1% | 182 | $2K |
| UBS Group AG | 0.00% | No change | 100 | $900 |
| Truvestments Capital LLC | 0.00% | No change | 22 | $198 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 15 | $135 |
| Lindbrook Capital, LLC | 0.00% | Reduce -95.0% | 15 | $135 |
| Nemes Rush Group LLC | 0.00% | New | 3 | $27 |
"% of holder's portfolio" is ONCT's weight in each manager's 13F, not the share of Oncternal Therapeutics Inc. the manager owns.